United States
As a biomedical scientist with an MBA, I bridge the gap between science and business, driving innovation in health tech and biotech. Through my career I have made several scientific discoveries, published them, translated some into startups, developed go-to market and corporate strategies, led corporate communications, raised money, led investments, worked on in-licensing and out-licensing deals in biotech and digital health space across several disease areas. Every day, I am privileged to collaborate with brilliant minds to translate cutting-edge science into real-world impact. I am focused on building meaningful relationships, identifying strategic opportunities, and advancing the vision and mission of the teams I work with. I remain actively engaged in scientific research and volunteer as a mentor and advisor.
NodThera is a clinical-stage biotech company developing a portfolio of NLRP3 inhibitors. I lead business development, investor relations and corporate communications.
Lead BD and strategic investments Board member of PortCos